Top compounds associated with response to SPTY2D1-AS1


Feature Type Standardized
Nominal ANOVA
mRNA silmitasertib CTRPv2 pan-cancer AAC 0.063 0.1
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.059 0.1
mRNA BRD9876 CTRPv2 pan-cancer AAC 0.062 0.1
mRNA SB-431542 CTRPv2 pan-cancer AAC -0.062 0.1
mRNA CAY10576 CTRPv2 pan-cancer AAC 0.063 0.1
mRNA BRD9647 CTRPv2 pan-cancer AAC -0.06 0.1
mRNA PD 153035 CTRPv2 pan-cancer AAC 0.066 0.1
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.057 0.1
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.055 0.1
Download CSV